Eosinophilic Myositis (Masticatory Muscle Inflammation) in Dogs

Open table of contents

When to visit the vet?

Urgent see a veterinarian within 24 hours

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Eosinophilic Myositis, also known as Masticatory Muscle Inflammation, is an inflammatory disease of the chewing muscles in dogs, characterized by an abnormal accumulation of eosinophilic cells, a type of white blood cell. This disease leads to Pain, Swelling, and loss of function of the affected muscles.

The most important facts at a glance

Eosinophilic Myositis, also known as Masticatory Muscle Inflammation, is an autoimmune disease in dogs in which the immune system mistakenly attacks the chewing muscles, especially the temporalis and masseter muscles. This inflammation is caused by eosinophilic granulocytes, a type of Immunzellen. Although the exact causes are unknown, genetic predispositions, environmental factors, and infections may play a role. Certain dog breeds, such as the German Shepherd and the Golden Retriever, show a higher susceptibility. Symptoms include exophthalmos, Masseter muscle swelling, Difficulty eating and Schmerzen when opening the jaw. The Diagnosis is made through clinical examinations, Blutuntersuchung and imaging procedures. A muscle biopsy can provide a definitive Diagnosis. The Therapie aims to reduce inflammation and restore muscle activity, usually through Kortikosteroide. An acute therapy may require high-dose Steroide, followed by a gradual reduction in dose. Long-term maintenance therapies may be necessary to prevent relapses. The Prognose is good with early Diagnosis and treatment, but left untreated, the disease can lead to permanent muscle changes. Preventive measures are difficult because the causes are not fully understood. However, a balanced diet and regular veterinary check-ups are helpful to promote the dog’s health.

Causes

Masticatory muscle myositis is an autoimmune disease in which the body’s own immune system mistakenly attacks the muscle fibers responsible for chewing. These muscles predominantly include the temporalis and masseter muscles. The inflammation is caused by an Infiltration of eosinophilic granulocytes, a specific type of Immunzellen.

The exact causes of Eosinophilic Myositis are not fully understood, but it is believed that genetic predispositions, environmental factors, and possibly infections could play a role. In some dog breeds, such as the German Shepherd and the Golden Retriever, there appears to be a genetic predisposition that increases the risk of developing this disease.

Another possible factor could be a reaction to certain medications or vaccines that affect the immune system. However, these connections have not been clearly proven and require further research to fully understand them.

Symptoms

The symptoms of Eosinophilic Myositis are often sudden and severe. One of the most common signs is Masseter muscle swelling, which prevents the dog from fully opening its mouth. This can lead to Difficulty eating and drinking, which is sometimes referred to as “trismus.”

In addition, affected dogs may show Pain in the jaw muscles and exhibit Sensitivity to touch. In some cases, Weight loss may also occur because the dog eats less due to the Pain.

Another common symptom is Fever, which is triggered by the inflammatory response in the body. Some dogs also show general signs of discomfort, such as lethargy and decreased activity.

Diagnosis

The Diagnosis of Eosinophilic Myositis is usually made through a combination of clinical examination, Blutuntersuchung and imaging procedures. During the clinical examination, the veterinarian checks the chewing muscles for Swelling and Schmerzen. A complete blood count may show an increased number of eosinophilic granulocytes, indicating an inflammatory response.

A definitive Diagnosis can be made by a muscle biopsy, in which a sample of the affected muscle is taken and examined histopathologisch. This examination typically shows an Infiltration of eosinophilic cells and other inflammatory changes in the muscle fibers.

In some cases, imaging techniques such as Ultraschall or MRI can also be used to assess the extent of the inflammation and possible Muskelatrophie. These methods help to rule out other possible causes for the symptoms.

Therapy

The treatment of Eosinophilic Myositis aims to reduce inflammation and restore muscle activity. This is mainly achieved through the administration of immunosuppressive drugs such as Kortikosteroide. These medications work by suppressing the activity of the immune system, thereby reducing the inflammatory response.

In acute cases, a high-dose Steroidtherapie may be necessary to quickly control the symptoms. Once the symptoms have subsided, the dose is gradually reduced to minimize side effects. Long-term, a low-dose maintenance therapy may be necessary to prevent relapses.

In addition to drug therapy, supportive care, such as special diets or nutritional supplements, can be helpful to improve nutrient absorption and support the healing process.

Prognosis and follow-up care

The Prognose for dogs with Eosinophilic Myositis varies depending on the severity of the disease and the response to treatment. With early Diagnosis and appropriate Therapie, many dogs have a good Prognose and can lead a relatively normal life.

However, some dogs are at risk of relapse, especially if treatment is stopped too early or the immune system is reactivated. In such cases, long-term maintenance therapy may be necessary to keep the disease under control.

Left untreated, Eosinophilic Myositis can lead to permanent muscle changes and loss of function, which significantly limits the quality of life of the affected dog.

Prevention

Since the exact causes of Eosinophilic Myositis are not yet fully understood, there are no specific prevention measures. However, some general measures can help to reduce the risk of disease.

A balanced diet and regular veterinary check-ups are important to promote the dog’s general health and detect potential problems early. In addition, Kontakt with potential triggers of autoimmune reactions, such as certain medications or vaccines, should be discussed with the veterinarian.

In dogs that are genetically predisposed, regular check-ups can help to detect signs of the disease early and start treatment quickly.

Outlook on current research

Outlook on research into Eosinophilic Myositis (Masticatory Muscle Myositis)

Eosinophilic Myositis or Masticatory Muscle Myositis (MMM) is now understood as a targeted autoimmune disease against 2M muscle fibers of the chewing muscles. Basic research focuses on which Immunzellen and signaling pathways (B cells, T cells, cytokines) drive autoantibody formation and chronic inflammation and why certain breeds (e.g. German Shepherd, Weimaraner) are particularly affected.

Diagnostically, the 2M antibody test remains a key tool, but is not perfect: antibody titers do not always correlate cleanly with clinical activity. Therefore, imaging and functional markers (e.g. CT/MRI of the chewing muscles, Ultraschall, measurement of the mouth opening angle) are systematically investigated to enable earlier Diagnosis and better therapy follow-up.

Therapeutically, the focus is shifting away from pure high-dose cortisone therapy towards individual, lower-side-effect Immunsuppression protocols (e.g. combination with cyclosporine, mycophenolate, leflunomide). A recent report describes the use of a selective JAK-1 inhibitor (oclacitinib) with clinical improvement with reduced steroid load – an indication of future targeted immunomodulation instead of broad Immunsuppression.

In the future, genetic risk profiles, refined autoantibody tests and standardized outcome measures (mouth opening angle, muscle volume, quality of life) are expected to be combined to better predict relapses and adapt therapies early and precisely. Overall, the development is clearly moving towards earlier, precise diagnostics and tailored, steroid-sparing therapy.

Frequently asked questions (FAQs)

1. What is Eosinophilic Myositis in dogs?
An immune-mediated inflammation of the chewing muscles in which the immune system is specifically directed against 2M fibers of the chewing muscles.
2. Is that the same as Masticatory Muscle Myositis?
Yes. Eosinophilic Myositis, Masticatory Muscle Myositis and Atrophische Myositis essentially refer to the same disease of the chewing muscles.
3. Which dogs are particularly affected?
Mainly young to middle-aged large breeds (e.g. German Shepherd, Weimaraner, Retriever), but in principle any dog can be affected.
4. What are the signs of the disease?
Painful, swollen chewing muscles, Difficulty eating, reduced mouth opening radius, drooling, later significant Muskelatrophie on the head.
5. Is the disease painful?
Yes, especially in the acute phase. Many dogs refuse hard food or do not like to be touched on the head.
6. How is the Diagnosis made?
Clinical examination plus Blutuntersuchung, 2M antibody test and, if necessary, muscle biopsy; imaging procedures can supplement the assessment.
7. How is it treated?
The standard is a longer-term Immunsuppression with glucocorticoids, often combined with other immunosuppressants, which are slowly tapered off.
8. Are there new therapy approaches?
Yes, currently, for example, JAK-1 inhibitors are being discussed as a steroid-sparing option in individual cases and studies.
9. What is the Prognose?
Usually good to satisfactory with early Diagnosis and consistent Therapie; functional losses remain with late-detected, fibrotic Atrophie.
10. Does the disease come back?
Relapses are possible, especially if the medication is stopped too quickly. Long-term, controlled reduced therapy significantly reduces this risk.

Literature

Selva-O’Callaghan, A., Trallero-Araguás, E., & Grau, J. M. (2014). Eosinophilic myositis: an updated review. Autoimmunity Reviews, 13(4-5), 375-378.
Reiter, A. M., & Schwarz, T. (2007). Computed tomographic appearance of masticatory myositis in dogs: 7 cases (1999–2006). Journal of the American Veterinary Medical Association, 231(6), 924-930.